Demyelinating Disease Clinical Trial
Official title:
Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children
NCT number | NCT03010826 |
Other study ID # | 1000053920 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 2016 |
Est. completion date | November 16, 2018 |
Verified date | January 2020 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The neural circuits in our brains require a layer of insulation in order to transmit signals in a rapid and efficient fashion. This insulation is called White Matter and is comprised of a specific type of brain cell called an oligodendrocytes. Damage to brain white matter occurs following injury and in disorders like Multiple Sclerosis and results in sensory, motor, and cognitive problems. Currently there are no effective medical therapies to promote brain repair and reduce disability following damage to white matter. In this project, we hope to change the situation by encouraging the brain itself to generate new oligodendrocytes and thus new white matter. Our first step is to find measures sensitive to white matter growth.
Status | Completed |
Enrollment | 78 |
Est. completion date | November 16, 2018 |
Est. primary completion date | November 16, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 5 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Experienced a demyelinating event (Only applicable to patient subjects) - Between the ages of 5 years to 18 years and 11 months of age - Has either English as his or her native language or has had at least two years of schooling in English Exclusion Criteria: - Children with non-demyelinating etiologies of white matter dysfunction (i.e., metabolic disorders, vasculitis, and non-specific MRI abnormalities - Is younger than 5 years of age - Is 18 years and 11 of age or older - Has a prior history of traumatic brain injury, neurological disorder, cerebral palsy, developmental delay, or learning disability - Requires sedation for brain scanning - Is claustrophobic, as brain scanning requires children to enter a tunnel in the MRI machine |
Country | Name | City | State |
---|---|---|---|
Canada | Queen`s University | Kingston | Ontario |
Canada | Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Neuronal responses during pro/anti-saccade eye movements | Video-based eye tracking monocularly in the MEG and binocularly outside the MEG | 60 minutes | |
Primary | Electrical potentials initiated by brief visual stimuli | Visual Evoked Potentials (VEP) | 10 minutes | |
Primary | MRI scans of the brain, including Diffusion Tensor Imagine (DTI) | 90 minutes | ||
Primary | Neurocognitive Testing | Computerized Penn Neurocognitive Battery | 90 minutes | |
Primary | High contrast visual acuity | 10 minutes | ||
Primary | Low contrast visual acuity; colour vision; visual fields testing; OCT testing; | 10 minutes | ||
Primary | Colour vision testing | 10 minutes | ||
Primary | Visual fields testing | 20 minutes | ||
Primary | Optical coherence tomography (OCT) | 25 minutes | ||
Primary | Neurological Exam - Standard physical exam performed by neurologist to determine the Expanded Disability Status Scale (EDSS) score. | 20 minutes | ||
Primary | Clinical Interview | 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04997343 -
Neurophysiological Assessment in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT00001780 -
Magnetic Stimulation of the Human Nervous System
|
N/A |